Skip to content

Comparison of therapeutic effects of wrist-ankle acupuncture, compound diclofenac sodium injection, and morphine hydrochloride injection on renal colic

Comparison of therapeutic effects of wrist-ankle acupuncture, compound diclofenac sodium injection, and morphine hydrochloride injection on renal colic

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004450
Enrollment
Unknown
Registered
2020-11-05
Start date
2020-12-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal colic

Interventions

Sponsors

The Fifth affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) 18-65 years old, gender is not limited; (2) Acute renal entanglement with renal pelvis and ureteral stones confirmed by ultrasound, X-ray or CT examination, causing sudden severe waist and abdomen pain, dysuria, dysuria, etc. Pain patients; (3) stable vital signs, no symptoms of high fever, chills, etc.; (4) bilateral wrist and ankle joints without deformities, and no skin lesions; (5) voluntarily participate in this clinical trial and sign a written informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with severe heart, liver, kidney and other organ diseases or who cannot comply; (2) Uncontrollable systemic bleeding diseases; (3) Patients with high fever and chills that require immediate surgical intervention; (4) Pregnancy, Severe physical weakness; (5) Bilateral wrist and ankle joint deformities, skin lesions; (6) Non-steroidal anti-inflammatory drugs (NSAID) or hypersensitivity to morphine; (7) Other than urolithiasis Patients with renal colic caused by the causes of the disease; (8) Patients who have used other painkillers within 6 hours before treatment at this institution; (9) The investigator assessed the patients condition and deemed it unsuitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
heart rate;temperature;VAS score;ECG;Quality of life index score;Urine routine;Blood pressure;Concomitant symptoms after treatment;Abdominal imaging examination;Blood routine;Concomitant symptoms before treatment;

Countries

China

Contacts

Public ContactChen Jinlan

The Fifth affiliated Hospital of Guangzhou Medical University

lailan@163.com+86 13610266623

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026